X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (159008) 159008
Patent (39443) 39443
Publication (10125) 10125
Newspaper Article (1312) 1312
Conference Proceeding (1068) 1068
Book Review (1025) 1025
Book Chapter (744) 744
Magazine Article (350) 350
Book / eBook (253) 253
Dissertation (159) 159
Trade Publication Article (151) 151
Newsletter (107) 107
Government Document (85) 85
Web Resource (30) 30
Reference (19) 19
Data Set (18) 18
Paper (18) 18
Presentation (10) 10
Technical Report (8) 8
Report (5) 5
Market Research (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (134898) 134898
female (89054) 89054
male (73585) 73585
middle aged (63880) 63880
combined modality therapy (61499) 61499
adult (56535) 56535
index medicus (54185) 54185
antineoplastic combined chemotherapy protocols - therapeutic use (51882) 51882
aged (49895) 49895
oncology (49461) 49461
treatment outcome (34714) 34714
mechanical engineering (30059) 30059
antineoplastic combined chemotherapy protocols - adverse effects (30016) 30016
heating (29976) 29976
lighting (29815) 29815
weapons (29808) 29808
blasting (29806) 29806
combined heating and refrigeration systems (28476) 28476
heat pump systems (28476) 28476
liquefaction solidification of gases (28476) 28476
manufacture or storage of ice (28476) 28476
refrigeration or cooling (28476) 28476
chemotherapy (27072) 27072
cancer (23145) 23145
animals (19607) 19607
heat-pump systems (16816) 16816
refrigeration machines, plants or systems (16815) 16815
adolescent (16236) 16236
performing operations (14301) 14301
transporting (14301) 14301
aged, 80 and over (14241) 14241
care and treatment (14204) 14204
follow-up studies (13960) 13960
therapy (13284) 13284
prognosis (13145) 13145
neoplasm staging (12913) 12913
antineoplastic combined chemotherapy protocols - administration & dosage (12777) 12777
retrospective studies (12752) 12752
surgery (12006) 12006
cisplatin - administration & dosage (11404) 11404
refrigerators (11220) 11220
cold rooms (11213) 11213
cooling or freezing apparatus not covered by any othersubclass (11213) 11213
ice-boxes (11213) 11213
hematology (11127) 11127
machine tools (11081) 11081
metal-working not otherwise provided for (11077) 11077
mice (10956) 10956
survival rate (10909) 10909
child (10697) 10697
radiotherapy (10452) 10452
time factors (10114) 10114
drug administration schedule (10074) 10074
disease-free survival (10042) 10042
research (9802) 9802
fluorouracil - administration & dosage (9538) 9538
combined operations (9333) 9333
survival analysis (9229) 9229
other working of metal (9212) 9212
universal machine tools (9212) 9212
breast neoplasms - drug therapy (9098) 9098
analysis (9030) 9030
survival (8532) 8532
risk factors (8511) 8511
prospective studies (8432) 8432
dose-response relationship, drug (8117) 8117
antineoplastic agents - therapeutic use (8056) 8056
health aspects (7778) 7778
cisplatin (7703) 7703
lung neoplasms - drug therapy (7651) 7651
doxorubicin - administration & dosage (7458) 7458
cyclophosphamide - administration & dosage (7321) 7321
young adult (7315) 7315
pharmacology & pharmacy (7298) 7298
carcinoma (7296) 7296
medicine & public health (7260) 7260
trial (7019) 7019
child, preschool (6870) 6870
cell line, tumor (6673) 6673
general tagging of cross-sectional technologies spanning over several sections of the ipc (6666) 6666
general tagging of new technological developments (6666) 6666
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (6666) 6666
antineoplastic combined chemotherapy protocols - pharmacology (6456) 6456
chemotherapy, adjuvant (6373) 6373
tumors (6125) 6125
breast cancer (6062) 6062
remission induction (6035) 6035
drug therapy (5727) 5727
recurrence (5472) 5472
breast neoplasms - pathology (5304) 5304
apoptosis (5283) 5283
deoxycytidine - analogs & derivatives (5226) 5226
hematology, oncology and palliative medicine (5094) 5094
clinical trials (5057) 5057
technologies or applications for mitigation or adaptation againstclimate change (4974) 4974
infant (4954) 4954
drug synergism (4877) 4877
clinical trials as topic (4875) 4875
antineoplastic agents - administration & dosage (4833) 4833
medicine, general & internal (4823) 4823
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (75) 75
Gerstein Science - Stacks (51) 51
Collection Dvlpm't (Acquisitions) - Vendor file (31) 31
Engineering & Comp. Sci. - Stacks (25) 25
Online Resources - Online (24) 24
UTL at Downsview - May be requested (17) 17
UofT at Mississauga - Stacks (12) 12
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Trinity College (John W Graham) - Stacks (6) 6
UofT at Scarborough - Stacks (6) 6
OISE - Stacks (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
New College (Ivey) - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Business (Joseph L Rotman) - Stacks (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Criminology - Stacks (1) 1
Faculty of Information - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Searching (1) 1
Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (181181) 181181
Chinese (16981) 16981
Russian (6200) 6200
German (5904) 5904
Japanese (5298) 5298
French (4636) 4636
Korean (1152) 1152
Spanish (1059) 1059
Italian (457) 457
Polish (376) 376
Hungarian (181) 181
Dutch (172) 172
Portuguese (134) 134
Bulgarian (114) 114
Czech (114) 114
Ukrainian (111) 111
Norwegian (94) 94
Swedish (81) 81
Danish (78) 78
Turkish (51) 51
Serbian (43) 43
Finnish (42) 42
Romanian (39) 39
Hebrew (35) 35
Croatian (29) 29
Persian (24) 24
Slovak (18) 18
Lithuanian (9) 9
Icelandic (8) 8
Greek (7) 7
Bosnian (4) 4
Slovenian (4) 4
Arabic (2) 2
Indonesian (2) 2
Latvian (2) 2
Afrikaans (1) 1
Estonian (1) 1
Moldavian (1) 1
Sanskrit (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 10/2013, Volume 128, Issue 14, pp. 1495 - 1503
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2012, Volume 104, Issue 2, pp. 93 - 113
With the advent of targeted agents for the treatment of renal cell carcinoma (RCC), overall survival has improved, and patients are being treated continuously... 
TYROSINE KINASE INHIBITORS | CONTROLLED-TRIAL | INTERFERON-ALPHA | SUNITINIB TREATMENT | CANCER-PATIENTS | VENOUS THROMBOEMBOLISM | ONCOLOGY | HEART-FAILURE | DOUBLE-BLIND | EXPANDED ACCESS PROGRAM | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Hypothyroidism - chemically induced | Pneumonia - therapy | Anorexia - therapy | Humans | Drug Eruptions - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Kidney Neoplasms - metabolism | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Weight Loss - drug effects | Benzenesulfonates - adverse effects | Bevacizumab | TOR Serine-Threonine Kinases - antagonists & inhibitors | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Pyrroles - adverse effects | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Everolimus | Hypothyroidism - therapy | Wound Healing - drug effects | Molecular Targeted Therapy - methods | Sirolimus - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Sirolimus - analogs & derivatives | Europe | Gastrointestinal Tract - drug effects | Cardiovascular System - drug effects | Evidence-Based Medicine | Carcinoma, Renal Cell - metabolism | Indoles - adverse effects | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Anorexia - chemically induced | Kidney Neoplasms - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Drugs | Complications and side effects | Care and treatment | Adverse and side effects | Carcinoma, Renal cell | Research | Drug therapy | Antineoplastic agents
Journal Article
JOURNAL OF NEUROSCIENCE, ISSN 0270-6474, 07/2008, Volume 28, Issue 27, pp. 6974 - 6982
Feedforward inhibition of neurons is a fundamental component of information flow control in the brain. We studied the roles played by neurogliaform cells... 
AREA CA1 | SYNAPTIC VESICLE | NEUROSCIENCES | CA1 PYRAMIDAL NEURONS | CORTEX COMBINED SLICE | TRANSMITTER RELEASE | ENTORHINAL CORTEX | GABA(B) receptor | feedforward inhibition | SYNAPSES | temporoammonic path | Ca2+ imaging | interneuron | synaptic transmission | RAT HIPPOCAMPUS | INTERNEURONS | STRATUM-LACUNOSUM-MOLECULARE | Pyramidal Cells - metabolism | Neural Pathways - drug effects | Synaptic Transmission - physiology | Calcium - metabolism | gamma-Aminobutyric Acid - metabolism | Calcium Signaling - physiology | Neuroglia - drug effects | Neural Inhibition - physiology | Receptors, GABA-A - drug effects | Synaptic Transmission - drug effects | Interneurons - cytology | Pyramidal Cells - drug effects | Action Potentials - drug effects | Organ Culture Techniques | Baclofen - pharmacology | Receptors, GABA-B - drug effects | Calcium - pharmacology | Interneurons - drug effects | Neuroglia - physiology | Inhibitory Postsynaptic Potentials - physiology | Rats | Hippocampus - cytology | GABA Antagonists - pharmacology | Action Potentials - physiology | Hippocampus - metabolism | Animals | Interneurons - metabolism | Calcium Signaling - drug effects | Phosphinic Acids - pharmacology | GABA Agonists - pharmacology | Neural Pathways - cytology | Neural Pathways - metabolism | Receptors, GABA-A - metabolism | Propanolamines - pharmacology | Neural Inhibition - drug effects | Inhibitory Postsynaptic Potentials - drug effects | Receptors, GABA-B - metabolism | Index Medicus
Journal Article
Investigative Ophthalmology & Visual Science, ISSN 0146-0404, 08/2008, Volume 49, Issue 8, pp. 3402 - 3408
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2014, Volume 102, Issue 3, pp. 667 - 674.e3
Objective To determine consequences of lymphoma treatments on sperm characteristics and sperm DNA, and to evaluate predictors of sperm recovery. Design... 
Internal Medicine | Obstetrics and Gynecology | sperm DNA | sperm chromatin | radiotherapy | spermatogenesis | Hodgkin | Lymphoma | chemotherapy | DNA INTEGRITY | FERTILITY PRESERVATION | CHROMATIN-STRUCTURE | TESTICULAR CANCER | SPERMATOZOA | SEMEN QUALITY | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | HODGKINS-DISEASE | MEN | GONADAL DYSFUNCTION | Doxorubicin - therapeutic use | Sperm Count | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Mechlorethamine - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | DNA - radiation effects | Mechlorethamine - therapeutic use | Case-Control Studies | Cyclophosphamide - therapeutic use | Young Adult | Bleomycin - therapeutic use | Vinblastine - adverse effects | Adult | DNA - drug effects | Spermatogenesis - radiation effects | Spermatogenesis - drug effects | Prednisone - adverse effects | Spermatozoa - radiation effects | Semen Analysis | Combined Modality Therapy | Bleomycin - adverse effects | Spermatozoa - drug effects | DNA - chemistry | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Non-Hodgkin - therapy | Hodgkin Disease - therapy | Vincristine - therapeutic use | Vincristine - adverse effects | Spermatozoa - physiology | DNA Damage | Longitudinal Studies | Doxorubicin - adverse effects | Prednisone - therapeutic use | Care and treatment | Spermatozoa | Lymphomas | Drug therapy | DNA | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 1, pp. 155 - 163
Purpose To quantify changes in bone marrow fat fraction and determine associations with peripheral blood cell counts. Methods and Materials In this prospective... 
Radiology | Hematology, Oncology and Palliative Medicine | ACUTE HEMATOLOGIC TOXICITY | CANCER-PATIENTS | MODELS | ONCOLOGY | CONCURRENT CHEMOTHERAPY | QUANTIFICATION | DECOMPOSITION | MALIGNANCIES | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | GYNECOLOGIC CANCER | WATER | Prospective Studies | Humans | Middle Aged | Male | Prostatic Neoplasms - therapy | Bone Marrow - anatomy & histology | Aged, 80 and over | Cetuximab | Paclitaxel - administration & dosage | Uterine Cervical Neoplasms - therapy | Adipose Tissue - anatomy & histology | Bone Marrow - drug effects | Radiotherapy Dosage | Chemoradiotherapy - methods | Lumbar Vertebrae - radiation effects | Fluorouracil - analogs & derivatives | Cervical Vertebrae - drug effects | Deoxycytidine - administration & dosage | Lumbar Vertebrae - drug effects | Blood Cell Count | Adipose Tissue - drug effects | Mitomycin - administration & dosage | Deoxycytidine - analogs & derivatives | Cervical Vertebrae - anatomy & histology | Thoracic Vertebrae - anatomy & histology | Chemoradiotherapy - adverse effects | Capecitabine | Magnetic Resonance Imaging - methods | Bone Marrow - radiation effects | Spine - drug effects | Thoracic Vertebrae - radiation effects | Radiotherapy, Intensity-Modulated - adverse effects | Spine - anatomy & histology | Cisplatin - administration & dosage | Adipose Tissue - radiation effects | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Spine - radiation effects | Anus Neoplasms - therapy | Adult | Bone Marrow Cells - drug effects | Female | Thoracic Vertebrae - drug effects | Bone Marrow Cells - radiation effects | Lumbar Vertebrae - anatomy & histology | Rectal Neoplasms - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endometrial Neoplasms - therapy | Aged | Cervical Vertebrae - radiation effects | Chemotherapy | Radiotherapy | Radiation | Cancer | PATIENTS | URACILS | BIOMEDICAL RADIOGRAPHY | BONE MARROW | MITOMYCIN | NEUTROPHILS | CORRELATIONS | RADIATION DOSES | TOXICITY | CHEMOTHERAPY | PLANNING | NMR IMAGING | RADIOLOGY AND NUCLEAR MEDICINE | FATS | HAZARDS
Journal Article
Molecular Oncology, ISSN 1574-7891, 08/2016, Volume 10, Issue 7, pp. 949 - 965
Development of therapeutic resistance is responsible for most prostate cancer (PCa) related mortality. Resistance has been attributed to an acquired or... 
Anticancer drugs | Mitochondria | Combination therapy | Prostate cancer | Unfolded protein response | Apoptosis | STEM-CELLS | STRESS-RESPONSE | DNA-DAMAGE | ESTRAMUSTINE PHOSPHATE | CELL-CYCLE ARREST | TUMOR-CELLS | PACLITAXEL | EPITHELIAL-MESENCHYMAL TRANSITION | LUNG-CANCER | ONCOLOGY | ENDOPLASMIC-RETICULUM | Cell Death - radiation effects | Prostatic Neoplasms - radiotherapy | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Membrane Potential, Mitochondrial - radiation effects | Neoplastic Stem Cells - drug effects | Humans | Unfolded Protein Response - radiation effects | Male | Interferon-gamma - metabolism | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Interleukin-8 - metabolism | Phosphorylation - drug effects | Prostatic Neoplasms - drug therapy | G2 Phase - radiation effects | Cytoskeleton - radiation effects | beta Catenin - metabolism | Cell Cycle Checkpoints - radiation effects | G1 Phase - radiation effects | Cell Cycle Checkpoints - drug effects | X-Rays | Cell Line, Tumor | Cytoskeleton - metabolism | Peptides, Cyclic - therapeutic use | Thapsigargin - pharmacology | Thapsigargin - therapeutic use | Prostatic Neoplasms - metabolism | Apoptosis - radiation effects | Peptides, Cyclic - pharmacology | G1 Phase - drug effects | Membrane Potential, Mitochondrial - drug effects | G2 Phase - drug effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Caspases - metabolism | Paclitaxel | Mitochondria - radiation effects | Cell Death - drug effects | Neoplastic Stem Cells - radiation effects | Prostatic Neoplasms - pathology | Unfolded Protein Response - drug effects | Mitochondria - metabolism | Mitochondria - drug effects | Enzyme Activation - drug effects | HSP70 Heat-Shock Proteins - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Matrix Metalloproteinases - metabolism | Transforming Growth Factor beta - metabolism | Cytoskeleton - drug effects | Care and treatment | Mortality | Oncology, Experimental | Mitochondrial DNA | Research | Drug resistance | Transforming growth factors | Nuclear radiation | Stem cells | Bone morphogenetic proteins | Germany | Cancer | Histone deacetylase | Phenotypes | Immunoglobulins | Transforming growth factor-b | Caspase | Metastasis | Cancer therapies | Cell adhesion & migration | Adenomatous polyposis coli | Thapsigargin | Androgens | Protein folding | CD44 antigen | Cell cycle | Conflicts of interest | Cytoskeleton
Journal Article
JAMA, ISSN 0098-7484, 01/2017, Volume 317, Issue 1, pp. 37 - 47
Journal Article
Anesthesiology, ISSN 0003-3022, 09/2007, Volume 107, Issue 3, pp. 427 - 436
Background: During the brain growth spurt, the brain develops and modifies rapidly. in rodents this period is neonatal, spanning the first weeks of life,... 
DEVELOPMENTAL NEUROTOXICITY | ENVIRONMENTAL AGENTS | OLFACTORY MUCOSAL METAPLASIA | DEVELOPING RAT-BRAIN | FETAL ALCOHOL SYNDROME | ANESTHESIOLOGY | ADULT MICE | PRENATAL ETHANOL EXPOSURE | GUINEA-PIG | HIPPOCAMPAL FUNCTION | PERMANENT CHANGES | Anti-Anxiety Agents - administration & dosage | Anesthetics, Intravenous - adverse effects | Apoptosis - drug effects | Male | Receptors, GABA-A | Anesthetics, Combined - adverse effects | Ketamine - administration & dosage | N-Methylaspartate - adverse effects | Ketamine - adverse effects | Anesthetics, Intravenous - administration & dosage | Time Factors | Behavior, Animal - drug effects | Propofol - administration & dosage | Thiopental - administration & dosage | Analgesics - adverse effects | Disease Models, Animal | Animals, Newborn | Diazepam - administration & dosage | Analgesics - administration & dosage | N-Methylaspartate - administration & dosage | Sodium Chloride - administration & dosage | GABA Antagonists - administration & dosage | Maze Learning - drug effects | GABA Antagonists - adverse effects | Brain - drug effects | Drug Synergism | Excitatory Amino Acid Agonists - administration & dosage | Thiopental - adverse effects | Anesthetics, Combined - administration & dosage | Animals | Neurodegenerative Diseases - chemically induced | Excitatory Amino Acid Agonists - adverse effects | Mice | Drug Combinations | Propofol - adverse effects | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Biomaterials, ISSN 0142-9612, 2012, Volume 34, Issue 1, pp. 262 - 274
Abstract Single-walled carbon nanotubes (SWNTs) are special nano-materials which exhibit interesting physical and chemical properties, presenting new... 
Advanced Basic Science | Dentistry | Photothermal therapy | NGR | RNAi | Tumor-targeting | Single-walled carbon nanotubes | MATERIALS SCIENCE, BIOMATERIALS | EFFICIENT INTRACELLULAR DELIVERY | GENE DELIVERY | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | QUANTUM DOTS | BREAST-CANCER CELLS | IN-VIVO | CHEMISTRY | AMINOPEPTIDASE-N | SIRNA | WATER | Organ Specificity - drug effects | Endocytosis - radiation effects | RNA Interference - drug effects | Apoptosis - drug effects | Apoptosis - radiation effects | Humans | Male | RNA, Messenger - metabolism | Spectroscopy, Fourier Transform Infrared | Drug Delivery Systems | Neoplasms - therapy | Telomerase - genetics | Transfection | Lasers | Polyethyleneimine - chemistry | Hyperthermia, Induced | Telomerase - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Polyethyleneimine - chemical synthesis | Cell Survival - drug effects | Endocytosis - drug effects | RNA, Messenger - genetics | Nanotubes, Carbon - ultrastructure | Combined Modality Therapy | RNA Interference - radiation effects | Cell Survival - radiation effects | Phototherapy | Organ Specificity - radiation effects | Animals | Nanotubes, Carbon - chemistry | Cell Line, Tumor | Gene Expression Regulation, Neoplastic - radiation effects | Mice | Mice, Inbred BALB C | Neoplasms - pathology | Oligopeptides - pharmacology | RNA, Small Interfering - metabolism | Cys